Radiofrequency Ablation of Liver Metastasis in Patients with Locally Controlled Pancreatic Ductal Adenocarcinoma

Jae Berm Park(Samsung Medical Center), Duck Jong Han(Asan Medical Center), Pyo Nyun Kim(Ulsan College), Young Hoon Kim(St. Mary's Medical Center), Jihun Kim(Ulsan College), Tae Won Kim(Asan Medical Center), Heung-Moon Chang(Asan Medical Center), Song Cheol Kim(Ulsan College)
Journal of Vascular and Interventional Radiology
April 21, 2012
10.1016/j.jvir.2012.01.080
Cited by 55

Related Papers

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
|The Lancet Oncology|2015|954
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|264